{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T11:57:01Z","timestamp":1717415821990},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Internist"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s00108-021-01220-9","type":"journal-article","created":{"date-parts":[[2021,12,8]],"date-time":"2021-12-08T12:04:45Z","timestamp":1638965085000},"page":"1280-1289","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Was ist gesichert in der Therapie von autoinflammatorischen Fiebererkrankungen?"],"prefix":"10.1007","volume":"62","author":[{"given":"Anne","family":"Pankow","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugen","family":"Feist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrich","family":"Baumann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Kirschstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerd-R\u00fcdiger","family":"Burmester","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annette Doris","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,12,8]]},"reference":[{"key":"1220_CR1","volume-title":"Immundefekt, kombinierter schwerer, durch Adenosin-Desaminase-Mangel","author":"Orphanet","year":"2013","unstructured":"Orphanet (2013) Immundefekt, kombinierter schwerer, durch Adenosin-Desaminase-Mangel"},{"key":"1220_CR2","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1002\/acr.23446","volume":"70","author":"S Akar","year":"2018","unstructured":"Akar\u00a0S, Cetin\u00a0P, Kalyoncu\u00a0U et al (2018) Nationwide experience with off-label use of interleukin\u20111 targeting treatment in familial mediterranean fever patients. Arthritis Care Res 70:1090\u20131094","journal-title":"Arthritis Care Res"},{"key":"1220_CR3","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1002\/art.24458","volume":"61","author":"E Ben-Chetrit","year":"2009","unstructured":"Ben-Chetrit\u00a0E, Touitou\u00a0I (2009) Familial mediterranean fever in the world. Arthritis Rheum 61:1447\u20131453","journal-title":"Arthritis Rheum"},{"key":"1220_CR4","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1136\/annrheumdis-2016-210802","volume":"76","author":"R Caorsi","year":"2017","unstructured":"Caorsi\u00a0R, Penco\u00a0F, Grossi\u00a0A et\u00a0al (2017) ADA2 deficiency (DADA2) as an unrecognised cause of early onset polyarteritis nodosa and stroke: a\u00a0multicentre national study. Ann Rheum Dis 76:1648\u20131656","journal-title":"Ann Rheum Dis"},{"key":"1220_CR5","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1093\/rheumatology\/key006","volume":"58","author":"SJ Carter","year":"2019","unstructured":"Carter\u00a0SJ, Tattersall\u00a0RS, Ramanan\u00a0AV (2019) Macrophage activation syndrome in adults: recent advances in pathophysiology, diagnosis and treatment. Rheumatology 58:5\u201317","journal-title":"Rheumatology"},{"key":"1220_CR6","first-page":"15","volume":"4","author":"C Diesinger","year":"2017","unstructured":"Diesinger\u00a0C, Schriever\u00a0J (2017) Colchicin \u2013 gut informieren, vorsichtig dosieren. Bull Arzneimittelsich 4:15\u201323","journal-title":"Bull Arzneimittelsich"},{"key":"1220_CR7","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1084\/jem.20050640","volume":"201","author":"CA Dinarello","year":"2005","unstructured":"Dinarello\u00a0CA (2005) Blocking IL\u20111 in systemic inflammation. J\u00a0Exp Med 201:1355\u20131359","journal-title":"J Exp Med"},{"key":"1220_CR8","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/s41584-018-0081-x","volume":"14","author":"E Feist","year":"2018","unstructured":"Feist\u00a0E, Mitrovic\u00a0S, Fautrel\u00a0B (2018) Mechanisms, biomarkers and targets for adult-onset Still\u2019s disease. Nat Rev Rheumatol 14:603\u2013618","journal-title":"Nat Rev Rheumatol"},{"key":"1220_CR9","first-page":"668","volume":"36","author":"E Feist","year":"2018","unstructured":"Feist\u00a0E, Quartier\u00a0P, Fautrel\u00a0B et al (2018) Efficacy and safety of canakinumab in patients with Still\u2019s disease: exposure-response analysis of pooled systemic juvenile idiopathic arthritis data by age groups. Clin Exp Rheumatol 36:668\u2013675","journal-title":"Clin Exp Rheumatol"},{"key":"1220_CR10","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/8562485","author":"C Gaggiano","year":"2020","unstructured":"Gaggiano C, Vitale A, Obici L, Merlini G, Soriano A, Viapiana O, Cattalini M, Maggio MC, Lopalco G, Montin D, Jaber MA, Dagna L, Manna R, Insalaco A, Piga M, La Torre F, Berlengiero V, Gelardi V, Ciarcia L, Emmi G, Ruscitti P, Caso F, Cimaz R, Hern\u00e1ndez-Rodr\u00edguez J, Parronchi P, Sicignano LL, Verrecchia E, Iannone F, Sota J, Grosso S, Salvarani C, Frediani B, Giacomelli R, Mencarelli MA, Renieri A, Rigante D, Cantarini L. (2020) Clinical features at onset and genetic characterization of pediatric and adult patients with TNF-alpha receptor-associated periodic syndrome (TRAPS): a series of 80 cases from the AIDA network. Mediators Inflamm. https:\/\/doi.org\/10.1155\/2020\/8562485","journal-title":"Mediators Inflamm."},{"key":"1220_CR11","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/S0950-3579(05)80121-9","volume":"8","author":"BP Hazenberg","year":"1994","unstructured":"Hazenberg\u00a0BP, van Rijswijk\u00a0MH (1994) Clinical and therapeutic aspects of AA amyloidosis. Baillieres Clin Rheumatol 8:661\u2013690","journal-title":"Baillieres Clin Rheumatol"},{"key":"1220_CR12","doi-asserted-by":"publisher","first-page":"971","DOI":"10.3389\/fimmu.2020.00971","volume":"11","author":"V Hentgen","year":"2020","unstructured":"Hentgen\u00a0V, Vinit\u00a0C, Fayand\u00a0A et al (2020) The use of interleukine\u20111 inhibitors in familial mediterranean fever patients: a narrative review. Front Immunol 11:971. https:\/\/doi.org\/10.3389\/fimmu.2020.00971","journal-title":"Front Immunol"},{"key":"1220_CR13","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.semarthrit.2015.10.003","volume":"45","author":"K Hofheinz","year":"2016","unstructured":"Hofheinz\u00a0K, Schett\u00a0G, Manger\u00a0B (2016) Adult onset Still\u2019s disease associated with malignancy - cause or coincidence? Semin Arthritis Rheum 45:621\u2013626","journal-title":"Semin Arthritis Rheum"},{"key":"1220_CR14","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s00393-018-0588-1","volume":"78","author":"T Kallinich","year":"2019","unstructured":"Kallinich\u00a0T, Blank\u00a0N, Braun\u00a0T et al (2019) Evidence-based treatment recommendations for familial Mediterranean fever. A joint statement by the society for pediatric and adolescent rheumatology and the German society for rheumatology. Z\u00a0Rheumatol 78:91\u2013101","journal-title":"Z Rheumatol"},{"key":"1220_CR15","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1136\/annrheumdis-2018-213920","volume":"77","author":"Y Kaneko","year":"2018","unstructured":"Kaneko\u00a0Y, Kameda\u00a0H, Ikeda\u00a0K et al (2018) Tocilizumab in patients with adult-onset still\u2019s disease refractory to glucocorticoid treatment: a\u00a0randomised, double-blind, placebo-controlled phase III trial. Ann Rheum Dis 77:1720\u20131729","journal-title":"Ann Rheum Dis"},{"key":"1220_CR16","doi-asserted-by":"publisher","DOI":"10.1080\/14712598.2021.1942832","author":"Y Kaneko","year":"2021","unstructured":"Kaneko\u00a0Y, Takeuchi\u00a0T (2021) Interleukin\u20116 inhibition: a therapeutic strategy for the management of adult-onset Still\u2019s disease. Expert Opin Biol Ther. https:\/\/doi.org\/10.1080\/14712598.2021.1942832","journal-title":"Expert Opin Biol Ther"},{"key":"1220_CR17","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1055\/s-0042-118879","volume":"42","author":"C Kedor","year":"2017","unstructured":"Kedor\u00a0C, Feist\u00a0E (2017) Adult-onset Still\u2019s disease: new developments in diagnostics and treatment. Akt Rheumatol 42:37\u201345","journal-title":"Akt Rheumatol"},{"key":"1220_CR18","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1136\/annrheumdis-2020-217155","volume":"79","author":"C Kedor","year":"2020","unstructured":"Kedor\u00a0C, Listing\u00a0J, Zernicke\u00a0J et al (2020) Canakinumab for treatment of adult-onset Still\u2019s disease to achieve reduction of arthritic manifestation (CONSIDER): phase II, randomised, double-blind, placebo-controlled, multicentre, investigator-initiated trial. Ann Rheum Dis 79:1090\u20131097","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"1220_CR19","doi-asserted-by":"publisher","first-page":"e001227","DOI":"10.1136\/rmdopen-2020-001227","volume":"6","author":"JB Kuemmerle-Deschner","year":"2020","unstructured":"Kuemmerle-Deschner\u00a0JB, Gautam\u00a0R, George\u00a0AT et al (2020) Systematic literature review of efficacy\/effectiveness and safety of current therapies for the treatment of cryopyrin-associated periodic syndrome, hyperimmunoglobulin D syndrome and tumour necrosis factor receptor-associated periodic syndrome. RMD Open 6(2):e1227. https:\/\/doi.org\/10.1136\/rmdopen-2020-001227","journal-title":"RMD Open"},{"key":"1220_CR20","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1056\/NEJMoa070265","volume":"356","author":"HJ Lachmann","year":"2007","unstructured":"Lachmann\u00a0HJ, Goodman\u00a0HJ, Gilbertson\u00a0JA et\u00a0al (2007) Natural history and outcome in systemic AA amyloidosis. N\u00a0Engl J Med 356:2361\u20132371","journal-title":"N Engl J Med"},{"key":"1220_CR21","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1093\/rheumatology\/kep140","volume":"48","author":"E Lainka","year":"2009","unstructured":"Lainka\u00a0E, Neudorf\u00a0U, Lohse\u00a0P et\u00a0al (2009) Incidence of TNFRSF1A mutations in German children: epidemiological, clinical and genetic characteristics. Rheumatology (Oxford) 48:987\u2013991","journal-title":"Rheumatology (Oxford)"},{"key":"1220_CR22","first-page":"1708","volume":"21","author":"P Langevitz","year":"1994","unstructured":"Langevitz\u00a0P, Zemer\u00a0D, Livneh\u00a0A et\u00a0al (1994) Protracted febrile myalgia in patients with familial Mediterranean fever. J\u00a0Rheumatol 21:1708\u20131709","journal-title":"J Rheumatol"},{"key":"1220_CR23","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1016\/j.jaci.2019.12.908","volume":"145","author":"PY Lee","year":"2020","unstructured":"Lee\u00a0PY, Kellner\u00a0ES, Huang\u00a0Y et\u00a0al (2020) Genotype and functional correlates of disease phenotype in deficiency of adenosine deaminase 2 (DADA2). J\u00a0Allergy Clin Immunol 145:1664\u20131672.e10","journal-title":"J Allergy Clin Immunol"},{"key":"1220_CR24","doi-asserted-by":"publisher","first-page":"e678","DOI":"10.1016\/S2665-9913(21)00218-6","volume":"3","author":"F Leone","year":"2021","unstructured":"Leone\u00a0F, Cerasuolo\u00a0PG, Bosello\u00a0SL et al (2021) Adult-onset Still\u2019s disease following COVID-19 vaccination. Lancet Rheumatol 3:e678\u2013e680","journal-title":"Lancet Rheumatol"},{"key":"1220_CR25","doi-asserted-by":"publisher","first-page":"3986","DOI":"10.1093\/rheumatology\/keab485","volume":"60","author":"Y Ma","year":"2021","unstructured":"Ma\u00a0Y, Meng\u00a0J, Jia\u00a0J et al (2021) Current and emerging biological therapy in adult-onset Still\u2019s disease. Rheumatology (Oxford) 60:3986\u20134000","journal-title":"Rheumatology (Oxford)"},{"key":"1220_CR26","doi-asserted-by":"publisher","first-page":"e680","DOI":"10.1016\/S2665-9913(21)00219-8","volume":"3","author":"D Magliulo","year":"2021","unstructured":"Magliulo\u00a0D, Narayan\u00a0S, Ue\u00a0F et al (2021) Adult-onset Still\u2019s disease after mRNA COVID-19 vaccine. Lancet Rheumatol 3:e680\u2013e682","journal-title":"Lancet Rheumatol"},{"key":"1220_CR27","doi-asserted-by":"publisher","first-page":"619257","DOI":"10.3389\/fimmu.2020.619257","volume":"11","author":"H Malcova","year":"2020","unstructured":"Malcova\u00a0H, Strizova\u00a0Z, Milota\u00a0T et al (2020) IL\u20111 inhibitors in the treatment of monogenic periodic fever syndromes: from the past to the future perspectives. Front Immunol 11:619257","journal-title":"Front Immunol"},{"key":"1220_CR28","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1146\/annurev.immunol.25.022106.141627","volume":"27","author":"SL Masters","year":"2009","unstructured":"Masters\u00a0SL, Simon\u00a0A, Aksentijevich\u00a0I et\u00a0al (2009) Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease (*). Annu Rev Immunol 27:621\u2013668","journal-title":"Annu Rev Immunol"},{"key":"1220_CR29","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s10875-018-0525-8","volume":"38","author":"I Meyts","year":"2018","unstructured":"Meyts\u00a0I, Aksentijevich\u00a0I (2018) Deficiency of adenosine deaminase 2 (DADA2): updates on the phenotype, genetics, pathogenesis, and treatment. J\u00a0Clin Immunol 38:569\u2013578","journal-title":"J Clin Immunol"},{"key":"1220_CR30","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1007\/s00296-014-3205-x","volume":"35","author":"NA Mukhin","year":"2015","unstructured":"Mukhin\u00a0NA, Kozlovskaya\u00a0LV, Bogdanova\u00a0MV et\u00a0al (2015) Predictors of AA amyloidosis in familial Mediterranean fever. Rheumatol Int 35:1257\u20131261","journal-title":"Rheumatol Int"},{"key":"1220_CR31","first-page":"1878","volume":"58","author":"SRS Njonnou","year":"2019","unstructured":"Njonnou\u00a0SRS, Soyfoo\u00a0MS, Vandergheynst\u00a0FA (2019) Efficacy of sarilumab in adult-onset Still\u2019s disease as a\u00a0corticosteroid-sparing agent. Baillieres Clin Rheumatol 58:1878\u20131879","journal-title":"Baillieres Clin Rheumatol"},{"key":"1220_CR32","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1136\/annrheumdis-2015-208690","volume":"75","author":"S Ozen","year":"2016","unstructured":"Ozen\u00a0S, Demirkaya\u00a0E, Erer\u00a0B et\u00a0al (2016) EULAR recommendations for the management of familial Mediterranean fever. Ann Rheum Dis 75:644\u2013651","journal-title":"Ann Rheum Dis"},{"key":"1220_CR33","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1002\/art.40055","volume":"69","author":"J Rodriguez-Smith","year":"2017","unstructured":"Rodriguez-Smith\u00a0J, Lin\u00a0YC, Tsai\u00a0WL et al (2017) Cerebrospinal fluid cytokines correlate with aseptic meningitis and blood-brain barrier function in neonatal-onset multisystem inflammatory disease: central nervous system Biomarkers in neonatal-onset Multisystem inflammatory disease correlate with central nervous system inflammation. Arthritis Rheumatol 69:1325\u20131336","journal-title":"Arthritis Rheumatol"},{"key":"1220_CR34","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1097\/BOR.0b013e32834dd2d5","volume":"24","author":"S Savic","year":"2012","unstructured":"Savic\u00a0S, Dickie\u00a0LJ, Battellino\u00a0M et\u00a0al (2012) Familial Mediterranean fever and related periodic fever syndromes\/autoinflammatory diseases. Curr Opin Rheumatol 24:103\u2013112","journal-title":"Curr Opin Rheumatol"},{"key":"1220_CR35","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1002\/art.40147","volume":"69","author":"J Schepp","year":"2017","unstructured":"Schepp\u00a0J, Proietti\u00a0M, Frede\u00a0N et\u00a0al (2017) Screening of 181 patients with antibody deficiency for deficiency of adenosine deaminase 2 sheds new light on the disease in adulthood. Arthritis Rheumatol 69:1689\u20131700","journal-title":"Arthritis Rheumatol"},{"key":"1220_CR36","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1080\/1744666X.2019.1707664","volume":"16","author":"P Sfriso","year":"2020","unstructured":"Sfriso\u00a0P, Bindoli\u00a0S, Doria\u00a0A et al (2020) Canakinumab for the treatment of adult-onset Still\u2019s disease. Expert Rev Clin Immunol 16:129\u2013138","journal-title":"Expert Rev Clin Immunol"},{"key":"1220_CR37","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1002\/art.34409","volume":"64","author":"CH Sibley","year":"2012","unstructured":"Sibley\u00a0CH, Plass\u00a0N, Snow\u00a0J et al (2012) Sustained response and prevention of damage progression in patients with neonatal-onset multisystem inflammatory disease treated with anakinra: a\u00a0cohort study to determine three- and five-year outcomes. Arthritis Rheum 64:2375\u20132386","journal-title":"Arthritis Rheum"},{"key":"1220_CR38","doi-asserted-by":"publisher","first-page":"733","DOI":"10.3390\/jcm10040733","volume":"10","author":"S Tomaras","year":"2021","unstructured":"Tomaras\u00a0S, Goetzke\u00a0CC, Kallinich\u00a0T et al (2021) Adult-onset still\u2019s disease: clinical aspects and therapeutic approach. J\u00a0Clin Med 10:733","journal-title":"J Clin Med"},{"key":"1220_CR39","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.3906\/sag-2008-11","volume":"50","author":"A Tufan","year":"2020","unstructured":"Tufan\u00a0A, Lachmann\u00a0HJ (2020) Familial Mediterranean fever, from pathogenesis to treatment: a\u00a0contemporary review. Turk J Med Sci 50:1591\u20131610","journal-title":"Turk J Med Sci"},{"key":"1220_CR40","first-page":"75","volume":"10","author":"J van der Hilst","year":"2016","unstructured":"van der Hilst\u00a0J, Moutschen\u00a0M, Messiaen\u00a0PE et al (2016) Efficacy of anti-IL\u20111 treatment in familial Mediterranean fever: a\u00a0systematic review of the literature. Biologics 10:75\u201380","journal-title":"Biologics"},{"key":"1220_CR41","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1056\/NEJM198604173141601","volume":"314","author":"D Zemer","year":"1986","unstructured":"Zemer\u00a0D, Pras\u00a0M, Sohar\u00a0E et\u00a0al (1986) Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever. N\u00a0Engl J Med 314:1001\u20131005","journal-title":"N Engl J Med"},{"key":"1220_CR42","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1056\/NEJMoa1307361","volume":"370","author":"Q Zhou","year":"2014","unstructured":"Zhou\u00a0Q, Yang\u00a0D, Ombrello\u00a0AK et al (2014) Early-onset stroke and vasculopathy associated with mutations in ADA2. N\u00a0Engl J Med 370:911\u2013920","journal-title":"N Engl J Med"}],"container-title":["Der Internist"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-021-01220-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00108-021-01220-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-021-01220-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,8]],"date-time":"2021-12-08T13:03:29Z","timestamp":1638968609000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00108-021-01220-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":42,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1220"],"URL":"https:\/\/doi.org\/10.1007\/s00108-021-01220-9","relation":{},"ISSN":["0020-9554","1432-1289"],"issn-type":[{"value":"0020-9554","type":"print"},{"value":"1432-1289","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"9 November 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"A.\u00a0Pankow, E.\u00a0Feist, U.\u00a0Baumann, M.\u00a0Kirschstein, G.-R.\u00a0Burmester und A.D.\u00a0Wagner geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}